Annual Total Expenses
$28.88 M
+$15.86 M+121.80%
31 December 2023
Summary:
Sunshine Biopharma annual total expenses is currently $28.88 million, with the most recent change of +$15.86 million (+121.80%) on 31 December 2023. During the last 3 years, it has risen by +$28.23 million (+4354.54%). SBFMW annual total expenses is now at all-time high.SBFMW Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$9.54 M
-$1.03 M-9.74%
30 September 2024
Summary:
Sunshine Biopharma quarterly total expenses is currently $9.54 million, with the most recent change of -$1.03 million (-9.74%) on 30 September 2024. Over the past year, it has increased by +$2.80 million (+41.63%). SBFMW quarterly total expenses is now -9.74% below its all-time high of $10.57 million, reached on 30 June 2024.SBFMW Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +121.8% | +41.6% |
| 3 y3 years | +4354.5% | +1645.5% |
| 5 y5 years | +1689.5% | +4444.3% |
SBFMW Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +4354.5% | -9.7% | +2515.9% |
| 5 y | 5 years | at high | +4354.5% | -9.7% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -9.7% | +730.9% |
Sunshine Biopharma Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.54 M(-9.7%) |
| June 2024 | - | $10.57 M(+18.9%) |
| Mar 2024 | - | $8.89 M(+0.3%) |
| Dec 2023 | $28.88 M(+121.8%) | $8.87 M(+31.6%) |
| Sept 2023 | - | $6.74 M(+2.8%) |
| June 2023 | - | $6.55 M(-2.6%) |
| Mar 2023 | - | $6.72 M(-25.1%) |
| Dec 2022 | $13.02 M(+387.9%) | $8.98 M(+385.0%) |
| Sept 2022 | - | $1.85 M(+118.7%) |
| June 2022 | - | $846.10 K(-37.1%) |
| Mar 2022 | - | $1.35 M(+269.0%) |
| Dec 2021 | $2.67 M(+311.6%) | $364.75 K(-33.3%) |
| Sept 2021 | - | $546.63 K(+23.8%) |
| June 2021 | - | $441.47 K(-66.4%) |
| Mar 2021 | - | $1.32 M(+254.3%) |
| Dec 2020 | $648.28 K(-2.2%) | $371.33 K(+339.8%) |
| Sept 2020 | - | $84.44 K(-41.2%) |
| June 2020 | - | $143.71 K(+194.5%) |
| Mar 2020 | - | $48.80 K(-81.3%) |
| Dec 2019 | $662.76 K(-58.9%) | $261.15 K(+24.4%) |
| Sept 2019 | - | $209.97 K(+203.3%) |
| June 2019 | - | $69.23 K(-71.2%) |
| Mar 2019 | - | $240.53 K(-7.8%) |
| Dec 2018 | $1.61 M(+88.3%) | $260.98 K(-37.4%) |
| Sept 2018 | - | $416.69 K(-38.6%) |
| June 2018 | - | $678.20 K(+163.0%) |
| Mar 2018 | - | $257.87 K(+59.0%) |
| Dec 2017 | $857.19 K(-13.7%) | $162.18 K(+42.5%) |
| Sept 2017 | - | $113.81 K(-75.9%) |
| June 2017 | - | $472.22 K(+333.3%) |
| Mar 2017 | - | $108.99 K(-67.6%) |
| Dec 2016 | $993.11 K | $336.10 K(+189.7%) |
| Sept 2016 | - | $116.02 K(-75.4%) |
| June 2016 | - | $471.31 K(+576.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $69.68 K(-60.0%) |
| Dec 2015 | $781.99 K(-55.4%) | $174.24 K(+54.1%) |
| Sept 2015 | - | $113.05 K(-69.4%) |
| June 2015 | - | $369.87 K(+196.3%) |
| Mar 2015 | - | $124.83 K(-59.2%) |
| Dec 2014 | $1.76 M(-9.3%) | $306.30 K(+10.4%) |
| Sept 2014 | - | $277.43 K(-63.8%) |
| June 2014 | - | $765.51 K(+88.6%) |
| Mar 2014 | - | $405.87 K(-40.8%) |
| Dec 2013 | $1.94 M(+174.0%) | $685.41 K(+285.7%) |
| Sept 2013 | - | $177.68 K(+16.4%) |
| June 2013 | - | $152.59 K(-83.5%) |
| Mar 2013 | - | $922.89 K(+390.2%) |
| Dec 2012 | $706.68 K(+27.1%) | $188.26 K(-50.0%) |
| Sept 2012 | - | $376.41 K(+266.5%) |
| June 2012 | - | $102.69 K(+161.1%) |
| Mar 2012 | - | $39.33 K(-89.4%) |
| Dec 2011 | $556.20 K(+3.5%) | $372.06 K(+219.5%) |
| Sept 2011 | - | $116.44 K(+606.1%) |
| June 2011 | - | $16.49 K(-66.5%) |
| Mar 2011 | - | $49.22 K(-88.5%) |
| Dec 2010 | $537.38 K(+1960.6%) | $426.95 K(-128.2%) |
| Sept 2010 | - | -$1.51 M(-195.2%) |
| June 2010 | - | $1.59 M(+4483.3%) |
| Mar 2010 | - | $34.65 K(+8.3%) |
| Oct 2009 | - | $32.01 K(+516.5%) |
| July 2009 | - | $5191.00(+110.2%) |
| Apr 2009 | - | $2470.00(-26.3%) |
| Jan 2009 | - | $3353.00(-27.7%) |
| Oct 2008 | - | $4638.00(+9.3%) |
| July 2008 | $26.08 K(+98.7%) | $4243.00(-60.6%) |
| Apr 2008 | - | $10.78 K(+376.0%) |
| Jan 2008 | - | $2265.00(-74.2%) |
| Oct 2007 | - | $8788.00 |
| July 2007 | $13.12 K | - |
FAQ
- What is Sunshine Biopharma annual total expenses?
- What is the all time high annual total expenses for Sunshine Biopharma?
- What is Sunshine Biopharma annual total expenses year-on-year change?
- What is Sunshine Biopharma quarterly total expenses?
- What is the all time high quarterly total expenses for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly total expenses year-on-year change?
What is Sunshine Biopharma annual total expenses?
The current annual total expenses of SBFMW is $28.88 M
What is the all time high annual total expenses for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total expenses is $28.88 M
What is Sunshine Biopharma annual total expenses year-on-year change?
Over the past year, SBFMW annual total expenses has changed by +$15.86 M (+121.80%)
What is Sunshine Biopharma quarterly total expenses?
The current quarterly total expenses of SBFMW is $9.54 M
What is the all time high quarterly total expenses for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total expenses is $10.57 M
What is Sunshine Biopharma quarterly total expenses year-on-year change?
Over the past year, SBFMW quarterly total expenses has changed by +$2.80 M (+41.63%)